ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 엑소좀 기술 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년까지 CAGR 27.8%로 확대되어 2억 4,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 규제 진전, 생물의료공학 혁신, 임상검사 보급, 재생의료의 개발, 나노기술통합의 성장에 기인한다고 생각됩니다. 예측기간의 주요 동향은 치료의 진보, 진단 용도, 나노기술 통합, 연구 자금의 급증, 분리 기술의 개발 등이 있습니다.
향후 5년간의 성장률 27.8%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 부과는 일본과 스웨덴에서 수입되는 엑소좀 기반 치료 및 정제 시스템의 비용을 증가시키고, 임상 검사를 지연시키고, 생명공학 개발 비용을 증가시킬 수 있기 때문에 미국의 재생 의료를 혼란시킬 수 있습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 가해질 수 있습니다.
엑소좀 기술 시장의 성장이 예상되는 배경에는 만성 질환의 만연이 있습니다. 만성 질환은 3개월 이상 지속되는 지속적 또는 장기적인 영향을 특징으로 하며, 엑소좀 기술에 대한 수요를 창출하고 있습니다. 이러한 기술은 질병 특이적 바이오마커의 확인, 엑소좀 카고 분석에 의한 질병 진행의 모니터링, 표적 약물 전달의 촉진, 만성 질환에서의 면역조절에 중요한 역할을 합니다. 예를 들어, 2023년 1월 통계에 따르면 미국에서는 50세 이상에서 하나 이상의 만성 질환을 가진 사람의 수가 99.5% 증가했으며, 2020년 7,152만 2,000명에서 2050년에는 1억 4,266만명에 이를 것으로 예측됩니다. 호주는 2022년 7월 호주 보건복지실(AIHW)이 발표한 바에 따르면 인구의 47%, 1,160만 명이 10가지 만성 질환 중 적어도 하나를 앓고 있는 것으로 추정됩니다. 따라서 만성질환의 유병률 증가는 엑소좀 기술시장의 성장을 가속할 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 엑소좀 기술 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 엑소좀 기술 시장 : 성장률 분석
세계의 엑소좀 기술 시장 실적 : 규모와 성장, 2019-2024년
세계의 엑소좀 기술 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 엑소좀 기술 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 엑소좀 기술 시장 : 엑소좀 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
카고
비 카고
세계의 엑소좀 기술 시장 : 세포원별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
HEK293 세포
중간엽 줄기세포(MSC)
혈소판
적혈구
자연 살해 세포
기타
세계의 엑소좀 기술 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
치료
진단
세계의 엑소좀 기술 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
의료 제공업체
제약 및 바이오테크놀러지 기업
기타
세계의 엑소좀 기술 시장 : 카고별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
단백질
핵산(DNA, RNA)
지질
소분자
세계의 엑소좀 기술 시장 : 비 카고별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
엑소좀 막 성분
세포외 매트릭스 성분
제7장 지역별/국가별 분석
세계의 엑소좀 기술 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 엑소좀 기술 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
엑소좀 기술 시장 : 경쟁 구도
엑소좀 기술 시장 : 기업 프로파일
AEGLE Therapeutics
Aruna Bio Inc.
Carmine Therapeutics Inc.
Exosome Diagnostics Inc.
Creative Biolabs Inc.
제31장 기타 주요 기업 및 혁신 기업
Danaher Corporation
OmniSpirant Limited
Thermo Fisher Scientific Inc.
Fujifilm Holdings Corporation
Anjarium Biosciences
NOVADIP Biosciences SA
Exopharm Ltd.
Organicell Regenerative Medicine Inc.
Evox Therapeutics
Direct Biologics
ExoCan Healthcare Technologies Pvt. Ltd.
ExoCoBio
ExonanoRNA LLC
ILIAS Biologics Inc.
Illumina Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
엑소좀 기술 시장(2029년) : 새로운 기회를 제공하는 국가
엑소좀 기술 시장(2029년) : 새로운 기회를 제공하는 부문
엑소좀 기술 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Exosome technologies involve the utilization of exosomes, which are small extracellular vesicles originating from endosomes, across diverse fields such as regenerative medicine, biotechnology, and biomedical research. This technology holds promise for applications in diagnostics, especially in liquid biopsy-based diagnostics and projects focused on discovering biomarkers. Exosomes, due to their unique characteristics, can serve as diagnostic biomarkers for the early identification of diseases.
Two primary types of exosome technologies are loaded cargo and non-cargo. Loaded cargo pertains to exosomes that have been modified to carry specific cargos, including therapeutic agents, employing passive or active loading methods. These engineered exosomes are derived from various cell sources such as HEK293 cells, mesenchymal stem cells (MSCs), platelets, erythrocytes, natural killer cells, and others. They find applications in both therapeutics and diagnostics, with end-users encompassing healthcare providers, pharmaceutical and biotechnology companies, and other entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The exosome technologies market research report is one of a series of new reports from The Business Research Company that provides exosome technologies market statistics, including exosome technologies industry global market size, regional shares, competitors with an exosome technologies market share, detailed exosome technologies market segments, market trends and opportunities, and any further data you may need to thrive in the exosome technologies industry. This exosome technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The exosome technologies market size has grown exponentially in recent years. It will grow from $0.07 billion in 2024 to $0.09 billion in 2025 at a compound annual growth rate (CAGR) of 26.1%. The growth in the historic period can be attributed to therapeutic advancements, isolation technique developments, research funding boosts, regenerative medicine exploration, and clinical trials inception.
The exosome technologies market size is expected to see exponential growth in the next few years. It will grow to $0.24 billion in 2029 at a compound annual growth rate (CAGR) of 27.8%. The growth in the forecast period can be attributed to regulatory progress, biomedical engineering innovations, clinical trials proliferation, regenerative medicine development, and nanotechnology integration growth. Major trends in the forecast period include therapeutic advancements, diagnostic applications, nanotechnology integration, research funding surge, and the development of isolation techniques.
The forecast of 27.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. regenerative medicine by increasing costs for exosome-based therapeutics and purification systems imported from Japan and Sweden, potentially delaying clinical trials and raising biotech development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated growth in the exosome technologies market is driven by the increasing prevalence of chronic diseases. Chronic diseases, characterized by persistent or long-lasting effects lasting three months or more, are on the rise, creating a demand for exosome technologies. These technologies play a crucial role in identifying disease-specific biomarkers, monitoring disease progression through exosome cargo analysis, facilitating targeted drug delivery, and immune modulation in chronic conditions. For instance, statistics from January 2023 indicate that the number of individuals aged 50 years and older with one or more chronic illnesses in the United States is projected to increase by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020. In Australia, an estimated 47% of the population, or 11.6 million individuals, are affected by at least one of the ten selected chronic ailments, as reported by the Australian Institute of Health and Welfare (AIHW) in July 2022. Hence, the escalating prevalence of chronic diseases is expected to drive the growth of the exosome technologies market.
Increasing healthcare expenditure is expected to drive the growth of the exosome technologies market in the coming years. Healthcare expenditure represents the total funds allocated to healthcare services, goods, and activities within a specific healthcare system or economy over a defined period. This rising expenditure is a key factor in advancing exosome technologies, as it supports research and development, enables reimbursement for clinical applications, bolsters chronic disease management efforts, and enhances infrastructure. For example, in December 2022, the U.S.-based Centers for Medicare & Medicaid Services reported that U.S. healthcare spending grew by 4.1% to reach $4.5 trillion, a rise from the 3.2% increase in 2021. Consequently, growing healthcare spending is fueling the expansion of the exosome technologies market.
The exosome technology market is witnessing a prominent trend in the adoption of advanced exosome characterization technologies. Companies within this market are integrating new technologies to maintain their competitive standing. For example, in August 2022, Creative Biolabs Inc., a biotech company based in the United States, introduced the NanosightTM platform for exosome characterization, leveraging Nanosight technology. Nanosight is a nanoparticle tracking analysis (NTA) technique enabling the visualization and quantification of exosomes based on their size and concentration. By offering this platform, Creative Biolabs intends to equip researchers with sophisticated tools for the comprehensive characterization and analysis of exosomes, facilitating a deeper understanding of their properties and functions.
Major players in the exosome technology sector are embracing a strategic partnership approach, seeking to capitalize on synergies and expedite progress in this dynamically evolving field. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutually beneficial outcomes. In June 2023, RoosterBio Inc., a biotechnology firm based in the United States, forged a partnership with Repligen, a life sciences company focused on bioprocessing. This collaboration aims to accelerate the development of scalable and cost-effective exosome bioprocessing solutions, ultimately enhancing accessibility to exosome-based therapies for patients.
In August 2024, BioIVT LLC, a U.S.-based provider of biospecimen solutions, acquired ZenBio Inc. for an undisclosed sum. This acquisition enables BioIVT to strengthen its expertise in cell and tissue models, expanding its portfolio of high-quality biological products for use in research and drug development. ZenBio Inc., also based in the U.S., is a biotechnology company specializing in human exosome research products.
Major companies operating in the exosome technologies market include AEGLE Therapeutics, Aruna Bio Inc., Carmine Therapeutics Inc., Exosome Diagnostics Inc., Creative Biolabs Inc., Danaher Corporation, OmniSpirant Limited, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Anjarium Biosciences, NOVADIP Biosciences S.A., Exopharm Ltd., Organicell Regenerative Medicine Inc., Evox Therapeutics, Direct Biologics, ExoCan Healthcare Technologies Pvt. Ltd., ExoCoBio, ExonanoRNA LLC, ILIAS Biologics Inc., Illumina Inc., Invitrix Therapeutics, XOStem Inc., VivaZome Therapeutics Pty Ltd., Aethlon Medical Inc., Capricor Therapeutics, Codiak BioSciences, Exogenus Therapeutics, Exovita Biosciences, HansaBioMed Life Sciences, Hitachi Chemical Advanced Therapeutics Solutions
North America was the largest region in the exosome technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global exosome technologies market report during the forecast period. The regions covered in the exosome technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the exosome technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The exosome technologies market consists of revenues earned by entities by providing exosome technologies services such as vaccine development, biomarker production, exosome-based diagnostic testing, and therapeutic development. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome technologies market consists of sales of exosome isolation kits, purification reagents, characterization tools, analysis kits, and exosome-based therapeutic products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Exosome Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on exosome technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for exosome technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exosome technologies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Exosome Type: Loaded Cargos; Non-Cargo
2) By Cell Source: HEK293 Cells; Mesenchymal Stem Cells (MSCs); Platelets; Erythrocytes; Natural Killer Cells; Other Cell Sources
3) By Application: Therapeutics; Diagnostics
4) By End-Users: Health Care Providers; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Loaded Cargo: Proteins; Nucleic Acids (DNA, RNA); Lipids; Small Molecules
2) By Non-Cargo: Exosome Membrane Components; Extracellular Matrix Components
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Exosome Technologies Market Characteristics
3. Exosome Technologies Market Trends And Strategies
4. Exosome Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Exosome Technologies Growth Analysis And Strategic Analysis Framework
5.1. Global Exosome Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Exosome Technologies Market Growth Rate Analysis
5.4. Global Exosome Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Exosome Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Exosome Technologies Total Addressable Market (TAM)
6. Exosome Technologies Market Segmentation
6.1. Global Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Loaded Cargos
Non-Cargo
6.2. Global Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
HEK293 Cells
Mesenchymal Stem Cells (MSCs)
Platelets
Erythrocytes
Natural Killer Cells
Other Cell Sources
6.3. Global Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutics
Diagnostics
6.4. Global Exosome Technologies Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Health Care Providers
Pharmaceutical And Biotechnology Companies
Other End-Users
6.5. Global Exosome Technologies Market, Sub-Segmentation Of Loaded Cargo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proteins
Nucleic Acids (DNA, RNA)
Lipids
Small Molecules
6.6. Global Exosome Technologies Market, Sub-Segmentation Of Non-Cargo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Exosome Membrane Components
Extracellular Matrix Components
7. Exosome Technologies Market Regional And Country Analysis
7.1. Global Exosome Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Exosome Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
